<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.7" -->
<rss version="0.92">
<channel>
	<title>Kraig Labs</title>
	<link>http://wallstreetreportonline.com/KBLB/KBLBBlog</link>
	<description></description>
	<lastBuildDate>Mon, 28 Sep 2009 05:39:49 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Awaiting Developments from the Lab</title>
		<description>Stay tuned to KBLB for new info coming out of the lab.  We like what we hear and are waiting for full details.  Should be exciting to hear about the results of the increasing number of micoinjections.  Joe Noel </description>
		<link>http://wallstreetreportonline.com/KBLB/KBLBBlog/?p=9</link>
			</item>
	<item>
		<title>Update - Success in the Lab!</title>
		<description>The announcement Kraig made early last week was highly significant. The release used quite a few terms that probably confuse the vast majority of small-cap investors - after all, we are not genetic scientists are we? Let me take a moment to explain what was announced and why it's important.

The ...</description>
		<link>http://wallstreetreportonline.com/KBLB/KBLBBlog/?p=6</link>
			</item>
	<item>
		<title>Kraig Biocraft Labs (KBLB) Analyst Blog</title>
		<description>Thank you for accessing the analyst blog for Kraig Biocraft Laboratories (KBLB). We have been covering this company since June of 2008.  We are eagerly awaiting news of the latest developments occurring in the Notre Dame lab!

This company has some of the most brilliant genetic engineering scientists in the world ...</description>
		<link>http://wallstreetreportonline.com/KBLB/KBLBBlog/?p=3</link>
			</item>
</channel>
</rss>
